PALATIN TECHNOLOGIES, INC. / KING PHARMACEUTICALS, INC.

Company

PALATIN TECHNOLOGIES INC

Filed

November 16, 2005

Accession Number

0000950144-05-011955

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →